✦ LIBER ✦

Efficacy of a single dose hepatitis B depot vaccine

✍ Scribed by Lisa D. MacDonald; Antar Fuentes-Ortega; Leeladhar Sammatur; Marc Mansour

Book ID: 116963032
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 185 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.08.084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B vaccine booster dose: Low-do

Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose

✍ Joe P. Bryan; Philip MacArthy; Al Rudock; John P. Fogarty; Hugh Dowd; Llewellyn 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Immunogenicity of single dose live atten

Immunogenicity of single dose live attenuated hepatitis A vaccine

✍ Sheila Bhave; Ashish Bavdekar; Amita Sapru; Seema Bawangade; Anand Pandit 📂 Article 📅 2011 🏛 Indian Academy of Pediatrics 🌐 English ⚖ 106 KB

Efficacy of a short-schedule/high dose h

Efficacy of a short-schedule/high dose hepatitis B vaccination in drug users

✍ Suzanne Brissette; Marina Gomez; Jean Lambert; Bernard Willems 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Protective efficacy of hepatitis B vacci

Protective efficacy of hepatitis B vaccination

✍ MichaelC. Kew 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 319 KB

Pharmaceutical and immunological evaluat

Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres

✍ Li Feng; Xian Rong Qi; Xing Jun Zhou; Yoshie Maitani; Shi Cong Wang; Yang Jiang; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Immunogenicity of a five-microgram dose

Immunogenicity of a five-microgram dose of hepatitis B vaccine

✍ George Papaevangelou; Anastasia Roumeliotou-Karayannis; Charalambos Vissoulis; S 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

The immunogenicity of a 5-micrograms dose of vaccine (H-B-Vax, MSD) was evaluated in 50 young adults (17-19 years). Results were compared to our previous studies using similarly prepared vaccines using 20 micrograms and 10 micrograms per dose with the same trial protocol in a comparable population.